Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease (Q81381423)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Okamoto M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Okano A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Akamatsu S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Ashihara E

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Inaba T

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Takenaka H

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Katoh N

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Kishimoto S

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Shimazaki C

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

172-173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16239908%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403996

8 January 2020

exact match

0 references

cites work

Chronic graft-versus-host disease: where do we go from here?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403996

7 January 2021

Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403996

7 January 2021

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403996

7 January 2021

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403996

7 January 2021

Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403996

7 January 2021

Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403996

7 January 2021

Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403996

7 January 2021

Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403996

7 January 2021